Related Experiment Videos
HLA antigen expression and malignant mesothelioma
T I Christmas1, L S Manning, M R Davis
1Department of Medicine, University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands.
American Journal of Respiratory Cell and Molecular Biology
|September 1, 1991
Summary
Malignant mesothelioma cells express HLA class I antigens constitutively. Interferon-gamma (IFN-γ) can induce HLA class II expression, suggesting potential for immunotherapy in treating this cancer.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor expression of Human Leukocyte Antigen (HLA) impacts immune response, tumor progression, and metastasis.
- Interferons (IFNs) can upregulate HLA antigen expression, potentially contributing to anti-tumor activity.
- Malignant mesothelioma (MM) is an aggressive cancer with a poor prognosis, and its response to immunotherapy remains under-assessed.
Purpose of the Study:
- To investigate the constitutive and interferon-inducible expression of class I and class II HLA antigens on malignant mesothelioma (MM) cell lines.
- To assess the potential of IFNs to modulate HLA antigen expression in MM cells for therapeutic strategies.
Main Methods:
- Indirect immunofluorescence was used to analyze surface antigen expression.
- Northern blotting was employed to examine mRNA levels of HLA antigens.
- MM cell lines were treated with Interferon-alpha (IFN-α) and Interferon-gamma (IFN-γ).
Main Results:
- All examined MM cell lines constitutively expressed class I HLA antigens (HLA-A, HLA-B, HLA-C) but not class II.
- IFN-α treatment led to a marginal increase in class I surface expression but a significant increase in class I mRNA, suggesting maximal surface expression.
- IFN-γ increased class I mRNA in most cell lines and induced class II (DR) expression in three cell lines, with inducible DQ-beta mRNA but not surface antigen.
Conclusions:
- MM cells inherently express class I HLA antigens.
- Interferon-gamma shows potential in modulating HLA class II expression in MM, indicating a possible avenue for immunotherapy.
- Heterogeneous responses to IFNs highlight the complexity of HLA regulation in malignant mesothelioma.